Objective: The aim of this study is to evaluate the effectiveness of local teicoplanin (TEC) administration in diabetic patients who underwent surgery for tibial plafond fracture.
INTRODUCTION
Post-surgical infection (PSI) is a soft-tissue infection that occurs around the wound site (1) . The high risk of infection may occur in post-traumatic fractures compared to non-traumatic ones after surgery (2, 3) . PSI may be associated with trauma related to soft-tissue damage, contamination, systemic diseases, blood supply status, and other factors (3) . Incidence of infection after ankle fractures is 1%-8% (4). Risk factors for PSI are history of previous surgery, infection, history of radiotherapy, age, high ASA score, obesity, diabetes, smoking, and inappropriate wound care (5, 6) . Diabetes mellitus (DM) is a systemic disease associated with blood glucose metabolism and prepares the ground for additional systemic problems (6) . It is one of the important risk factors of wound infection after orthopedic surgery (6) . In patients with DM, the rate of PSI is 10%-60%, the rate of amputation after open ankle fracture is 42%, and the rate of mortality is 11% (7, 8) . TEC is a glycopeptide derivative antibiotic that acts as a bactericidal effect through the cell wall (8) . In in vitro and clinical studies, TEC have been shown to be effective on osteomyelitis and on severe systemic infections associated with gram-positive bacteria such as corynebacterium and methicillin-resistant staphylococcus aureus (MRSA) (9) . The aim of our study was to retrospectively evaluate the effect of local single-dose TEC on postoperative complications and functional outcomes in diabetic patients undergoing surgery due to tibial plafond fractures.
METHODS
After Local Ethics Committee Approval and patient inform consent were obtained; the hospital records of 154 patients who underwent open reduction and osteosynthesis with plate-screw fixation due to tibial plafond fractures between January 2007 and January 2016 were analyzed. The study was conducted in accordance with the principles of the Helsinki Declaration. The minimum follow-up period was 12 months. Patients with a previous history of ankle fracture, polytrauma, pathological fracture or Charcot neuropathy, and neurological and rheumatic comorbid diseases were excluded from the study. In the perioperative evaluation of 154 patients, there were 26 (16.8%) patients with DM using oral antidiabetic, insulin, or both. Four of the 26 cases (15.3%) were excluded from the study because their regular follow-up records were unavailable. The remaining 22 patients (84.7%) were divided into two groups based on local TEC administration. Before the surgery, a single 2-g dose of cefazolin (IV) was routinely administered as a prophylaxis in Group T (n=12) and Group C (the group in which local TEC was not administered, n=10). Cefazolin 1-g (BID) was administered postoperatively for 24 h. In patients with penicillin allergy, clindamycin was used instead of cefazolin. Antidiabetic drugs were discontinued on the day of surgery in all diabetic patients. In addition, subcutaneous intermittent insulin administration was performed according to perioperative insulin scale, and the blood glucose level was maintained <200 mg/dL (6) . Tibial plafond fractures were classified according to AO/Orthopedic Trauma Association (OTA) classification. AO/ OTA 43B and 43C fractures were included in the study. Through anteromedial approach, open reduction and osteosynthesis with plate-screw fixation were applied in all patients ( Figure 1 ). After osteosynthesis, 400 mg of local TEC was administered in the surrounding region of the plate-screw in Group T ( Figure 2 ). After bleeding control in both groups, the layers were properly closed. Superficial wound separation and wound site necrosis were considered as mild soft-tissue complications. The lesions with positive wound culture results and treated with non-surgical modalities (oral antibiotherapy and dressing) were considered as superficial wound infection; on the other hand, osteomyelitis, removal of the implant due to the colonized implant, presence of fistula requiring debridement, and requirement for parenteral antibiotics were considered as deep wound infection (10). In addition to the demographic data, Group T and Group K were evaluated in terms of ASA score, duration of operation (min), length of hospital stay (LOS, day), post-surgical superficial or deep wound infection, reoperation rate, and amputation rate.
Statistical Analysis
The Statistical Package for Social Sciences, version 22.0 (IBM SPSS Corp.; Armonk, NY, USA) program was used for statistical analysis. The data were analyzed with descriptive statistical methods (mean, standard deviation). The distribution of the data was analyzed using the Kolmogorov-Smirnov test. Independent samples t test was used for parametric values. The nonparametric data were analyzed with chi-square test. A p value of <0.05 was considered statistically significant.
RESULTS
The mean age was 59.91±7.82 years in Group T and 62.40±8.30 in Group C; there was no significant difference between both groups (p=0.479) ( Table 1) . Of the patients, 59.1% (n=13) were female and 40.9% (n=9) were male; the right side was affected in 54.5% (n=12) and left side in 45.5% patients (n=10). Of the patients who underwent surgery according to the AO/OTA classification, 63.6% patients (n=14) had type 3B, and 36.4% patients (n=8) had type 3C fractures. There was no statistically significant difference between the mean ASA scores of the patients (Group T: 2.00±0.95, Group C: 1.90±0.99; p=0.813). The mean duration of operation was 78.66±14.29 min in Group T and 79.90±17.41 min in Group C. There was no significant difference between these two groups in terms of this parameter (p=0.857). One superficial wound site problem was detected in both groups and they were cleared up with excessive dressing every other day. PSI was detected in a total of seven patients (31.8%): one superficial and one deep in Group T and one superficial and four deep in Group C. There was no significant difference in terms of superficial wound infection in both groups (Group C vs Group T, 10% vs 8.8%; p=0.895). Deep wound infection was significantly higher in Group C than in Group T (40% vs 8.3%, p=0.035). In the second-year follow-up, the reoperation rate in Group C was significantly higher than that in Group T (1.5±1.7 vs 0.16±0.57, p=0.02). The LOS was also significantly longer in Group C than in Group T (22.60±18.02 vs. 9.08±8.36, p=0.03). While no amputation was performed in any of the patients in Group T at the end of postoperative 2 years, it is noteworthy that transtibial amputation was performed in two patients in Group C (16.6%) due to chronic osteomyelitis. No cases of erythema, anaphylaxis, or local reaction due to local TEC administration were detected in any patient in Group T.
DISCUSSION
The most important finding of this study was that 400 mg local TEC administration decreased the rate of post-surgical deep infection in patients who underwent open surgery for tibial plafond fracture. When the literature was evaluated, a few studies related to local TEC administration in the wound site in diabetic patients were found. For example, Lalla et al. (11) reported that they administered local TEC in total knee arthroplasty patients without performing systemic prophylaxis after tourniquet, and there were no systemic and local complications. They also indicated that the infection rate was similar to that in knee prostheses in which systemic prophylaxis was applied, and this application could be safe and effective in comparison to traditional methods. This may be due to the fact that locally administered TEC reduces the perioperative contamination of the bacteria, which may form a biofilm layer and cause deep implant infection. Advanced microbiological studies are needed to clarify this issue. Fracture treatment in diabetes is considered to be an important and independent risk factor for wound infection in many orthopedic procedures such as spinal surgery (12, 13) . For example, Kline et al. (12) evaluated cases treated for tibial plafond fracture in their 2009 retrospective study, and they reported the rate of PSI as 71%, 43% of which were deep and 28% were superficial in the diabetic group; in the non-diabetic group, the rate of PSI was 19%, 9% of which was deep and 10% was superficial. Flynn et al. (14) also reported that the rate of infection was twice as high in diabetic patients who had undergone surgery after a closed ankle fracture than those who had not. Wukich et al. (15) found that the rate of infection in diabetic patients was four times higher in their study in terms of PSI and risk factors with 1000 patients who had undergone ankle surgery. In our study, a high rate of superficial wound site problem and postoperative infection was detected in diabetic plafond fracture surgery in accordance with the literature. Systemic complications such as diabetes-induced neuropathy, vasculopathy, and immune dysfunction may lead to trauma and the development of infection mechanisms. PSI constitutes 20% of all nosocomial infections in orthopedics (16) . It has been reported in the literature that PSI prolongs hospital stay by 12-20 days, increases the reoperation rate twofold, and leads to a threefold increase in hospital costs (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) . It also has negative effects on the quality of life and physical activity level (17) . In this study, PSI, LOS, and reoperation rates in Group T were found significantly lower than those in Group C. Although uncertain, the mechanism of local TEC treatment seems to be effective on reoperation rate and LOS by decreasing the rate of deep wound infection. TEC is a broad-spectrum antibiotic that can achieve high concentrations in all soft tissues except for cerebrospinal fluid, which has a long serum half-life against gram-positive aerobic and anaerobic organisms (18) . It is the most commonly used antibiotic in Europe for the treatment of osteomyelitis because it has less ototoxicity, nephrotoxicity, and fewer gastrointestinal side effects compared with vancomycin (19, 20) . It is reported that 65% of the serum concentration of TEC can be reached in bone within the 30th minute after IV administration (21) . In their study of animal model with MRSA osteomyelitis, Jia et al. (20) (22, 23) . In our study, the rate of PSI was found to be 27.3% in accordance with the literature. The use of a single-center, retrospective nature of the study with less number of patients, lack of long-term follow-up results, lack of all microbiological culture results, and lack of functional evaluation of the extremity are the limitations of our study.
CONCLUSION
Perioperative local TEC treatment has positive effects on deep wound infection, reoperation rates, and LOS in diabetic patients who undergo open reduction and plate fixation due to tibial plafond fracture.
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